-
Je něco špatně v tomto záznamu ?
The Role of Nutraceuticals in Statin Intolerant Patients
M. Banach, AM. Patti, RV. Giglio, AFG. Cicero, AG. Atanasov, G. Bajraktari, E. Bruckert, O. Descamps, DM. Djuric, M. Ezhov, Z. Fras, S. von Haehling, N. Katsiki, M. Langlois, G. Latkovskis, GBJ. Mancini, DP. Mikhailidis, O. Mitchenko, PM....
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, přehledy
NLK
Free Medical Journals
od 1983 do Před 1 rokem
Open Access Digital Library
od 1998-01-01
- MeSH
- dyslipidemie dietoterapie farmakoterapie MeSH
- klinická studie jako téma MeSH
- lidé MeSH
- potravní doplňky * MeSH
- statiny škodlivé účinky MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Statins are the most common drugs administered for patients with cardiovascular disease. However, due to statin-associated muscle symptoms, adherence to statin therapy is challenging in clinical practice. Certain nutraceuticals, such as red yeast rice, bergamot, berberine, artichoke, soluble fiber, and plant sterols and stanols alone or in combination with each other, as well as with ezetimibe, might be considered as an alternative or add-on therapy to statins, although there is still insufficient evidence available with respect to long-term safety and effectiveness on cardiovascular disease prevention and treatment. These nutraceuticals could exert significant lipid-lowering activity and might present multiple non-lipid-lowering actions, including improvement of endothelial dysfunction and arterial stiffness, as well as anti-inflammatory and antioxidative properties. The aim of this expert opinion paper is to provide the first attempt at recommendation on the management of statin intolerance through the use of nutraceuticals with particular attention on those with effective low-density lipoprotein cholesterol reduction.
1st Department of Internal Medicine Paracelsus Private Medical University Salzburg Austria
3rd Department of Internal Medicine 1st Medical Faculty Charles University Prague Czech Republic
Cardiology Clinic School of Medicine University of Athens Athens Greece
Cardiovascular Research Centre University of Zielona Gora Zielona Gora Poland
Department of Cardiology and Pneumology University of Göttingen Medical Center Göttingen Germany
Department of Cardiology Cliniques Universitaires Saint Luc Bruxells Belgium
Department of Epidemiology University of Alabama Birmingham Birmingham Alabama
Department of Internal Medicine Centres Hospitaliers Jolimont Haine Saint Paul Belgium
Department of Internal Medicine Faculty of Medicine University of Debrecen Debrecen Hungary
Department of Laboratory Medicine AZ Sint Jan Hospital Bruges Belgium
Department of Medicine and Surgery Sciences University of Bologna Bologna Italy
Department of Pharmacognosy University of Vienna Vienna Austria
Dyslipidaemia Department Institute of Cardiology AMS of Ukraine Kiev Ukraine
Heart Disease Prevention Program Division of Cardiology University of California Irvine California
Institute of Genetics and Animal Breeding of the Polish Academy of Sciences Jastrzebiec Poland
IRCCS San Raffaele Roma Rome Italy
Mount Sinai Heart Icahn School of Medicine at Mount Sinai New York New York
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19035156
- 003
- CZ-PrNML
- 005
- 20191008110843.0
- 007
- ta
- 008
- 191007s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jacc.2018.04.040 $2 doi
- 035 __
- $a (PubMed)29957236
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Banach, Maciej $u Department of Hypertension, Medical University of Lodz, and the Polish Mother's Memorial Hospital Research Institute (PMMHRI), Lodz, Poland; Cardiovascular Research Centre, University of Zielona Gora, Zielona Gora, Poland. Electronic address: maciejbanach77@gmail.com.
- 245 14
- $a The Role of Nutraceuticals in Statin Intolerant Patients / $c M. Banach, AM. Patti, RV. Giglio, AFG. Cicero, AG. Atanasov, G. Bajraktari, E. Bruckert, O. Descamps, DM. Djuric, M. Ezhov, Z. Fras, S. von Haehling, N. Katsiki, M. Langlois, G. Latkovskis, GBJ. Mancini, DP. Mikhailidis, O. Mitchenko, PM. Moriarty, P. Muntner, D. Nikolic, DB. Panagiotakos, G. Paragh, B. Paulweber, D. Pella, C. Pitsavos, Ž. Reiner, GMC. Rosano, RS. Rosenson, J. Rysz, A. Sahebkar, MC. Serban, D. Vinereanu, M. Vrablík, GF. Watts, ND. Wong, M. Rizzo, International Lipid Expert Panel (ILEP),
- 520 9_
- $a Statins are the most common drugs administered for patients with cardiovascular disease. However, due to statin-associated muscle symptoms, adherence to statin therapy is challenging in clinical practice. Certain nutraceuticals, such as red yeast rice, bergamot, berberine, artichoke, soluble fiber, and plant sterols and stanols alone or in combination with each other, as well as with ezetimibe, might be considered as an alternative or add-on therapy to statins, although there is still insufficient evidence available with respect to long-term safety and effectiveness on cardiovascular disease prevention and treatment. These nutraceuticals could exert significant lipid-lowering activity and might present multiple non-lipid-lowering actions, including improvement of endothelial dysfunction and arterial stiffness, as well as anti-inflammatory and antioxidative properties. The aim of this expert opinion paper is to provide the first attempt at recommendation on the management of statin intolerance through the use of nutraceuticals with particular attention on those with effective low-density lipoprotein cholesterol reduction.
- 650 _2
- $a klinická studie jako téma $7 D000068456
- 650 12
- $a potravní doplňky $7 D019587
- 650 _2
- $a dyslipidemie $x dietoterapie $x farmakoterapie $7 D050171
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a statiny $x škodlivé účinky $7 D019161
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Patti, Angelo Maria $u Biomedical Department of Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.
- 700 1_
- $a Giglio, Rosaria Vincenza $u Biomedical Department of Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.
- 700 1_
- $a Cicero, Arrigo F G $u Department of Medicine and Surgery Sciences, University of Bologna, Bologna, Italy.
- 700 1_
- $a Atanasov, Atanas G $u Institute of Genetics and Animal Breeding of the Polish Academy of Sciences, Jastrzebiec, Poland; Department of Pharmacognosy, University of Vienna, Vienna, Austria.
- 700 1_
- $a Bajraktari, Gani $u Clinic of Cardiology, University Clinical Centre of Kosovo, and the Medical Faculty, University of Prishtina, Prishtina, Kosovo.
- 700 1_
- $a Bruckert, Eric $u Institute of Cardiometabolism and Nutrition (ICAN), Endocrinology Department, Hopital Pitié Salpetrière, Paris, France.
- 700 1_
- $a Descamps, Olivier $u Department of Internal Medicine, Centres Hospitaliers Jolimont, Haine Saint-Paul, Belgium; Department of Cardiology, Cliniques Universitaires Saint-Luc, Bruxells, Belgium.
- 700 1_
- $a Djuric, Dragan M $u Institute of Medical Physiology "Richard Burian" Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
- 700 1_
- $a Ezhov, Marat $u National Cardiology Research Center, Moscow, Russia.
- 700 1_
- $a Fras, Zlatko $u Preventive Cardiology Unit, Department of Vascular Medicine, Division of Internal Medicine, University Medical Centre Ljubljana, and Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
- 700 1_
- $a von Haehling, Stephan $u Department of Cardiology and Pneumology, University of Göttingen Medical Center, Göttingen, Germany.
- 700 1_
- $a Katsiki, Niki $u Second Propaedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippocration Hospital, Thessaloniki, Greece.
- 700 1_
- $a Langlois, Michel $u Department of Laboratory Medicine, AZ Sint-Jan Hospital, Bruges, Belgium.
- 700 1_
- $a Latkovskis, Gustavs $u Faculty of Medicine and Institute of Cardiology and Regenerative Medicine, University of Latvia, Riga, Latvia.
- 700 1_
- $a Mancini, G B John $u Department of Medicine, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada.
- 700 1_
- $a Mikhailidis, Dimitri P $u Department of Clinical Biochemistry, Royal Free Campus, University College London Medical School, University College London (UCL), London, United Kingdom.
- 700 1_
- $a Mitchenko, Olena $u Dyslipidaemia Department, Institute of Cardiology AMS of Ukraine, Kiev, Ukraine.
- 700 1_
- $a Moriarty, Patrick M $u Division of Clinical Pharmacology, Division of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas.
- 700 1_
- $a Muntner, Paul $u Department of Epidemiology, University of Alabama Birmingham, Birmingham, Alabama.
- 700 1_
- $a Nikolic, Dragana $u Biomedical Department of Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.
- 700 1_
- $a Panagiotakos, Demosthenes B $u School of Health Science and Education, Department of Nutrition and Dietetics, Harokopio University of Athens, Athens, Greece.
- 700 1_
- $a Paragh, Gyorgy $u Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
- 700 1_
- $a Paulweber, Bernhard $u First Department of Internal Medicine, Paracelsus Private Medical University, Salzburg, Austria.
- 700 1_
- $a Pella, Daniel $u 1st Department of Internal Medicine, Faculty of Medicine, Pavol Jozef Safarik University, Košice, Slovakia.
- 700 1_
- $a Pitsavos, Christos $u Cardiology Clinic, School of Medicine, University of Athens, Athens, Greece.
- 700 1_
- $a Reiner, Željko $u University Hospital Centre Zagreb, School of Medicine University of Zagreb, Department of Internal Medicine, Zagreb, Croatia.
- 700 1_
- $a Rosano, Giuseppe M C $u Cardiovascular Clinical Academic Group St. George's Hospitals NHS Trust University of London, London, United Kingdom; IRCCS San Raffaele Roma, Rome, Italy.
- 700 1_
- $a Rosenson, Robert S $u Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, New York.
- 700 1_
- $a Rysz, Jacek $u Department of Hypertension, Medical University of Lodz, and the Polish Mother's Memorial Hospital Research Institute (PMMHRI), Lodz, Poland; Cardiovascular Research Centre, University of Zielona Gora, Zielona Gora, Poland.
- 700 1_
- $a Sahebkar, Amirhossein $u Biotechnology Research Center, Pharmaceutical Technology Institute and Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
- 700 1_
- $a Serban, Maria-Corina $u Department of Functional Sciences, Discipline of Pathophysiology, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania.
- 700 1_
- $a Vinereanu, Dragos $u University of Medicine and Pharmacy "Carol Davila," and Department of Cardiology, University and Emergency Hospital, Bucharest, Romania.
- 700 1_
- $a Vrablík, Michal $u Third Department of Internal Medicine, First Medical Faculty, Charles University, Prague, Czech Republic.
- 700 1_
- $a Watts, Gerald F $u Cardiometabolic Service, Department of Cardiology, Royal Perth Hospital, and School of Medicine, University of Western Australia, Perth, Western Australia, Australia.
- 700 1_
- $a Wong, Nathan D $u Heart Disease Prevention Program, Division of Cardiology, University of California, Irvine, California.
- 700 1_
- $a Rizzo, Manfredi $u Biomedical Department of Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.
- 710 2_
- $a International Lipid Expert Panel (ILEP)
- 773 0_
- $w MED00002964 $t Journal of the American College of Cardiology $x 1558-3597 $g Roč. 72, č. 1 (2018), s. 96-118
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29957236 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20191007 $b ABA008
- 991 __
- $a 20191008111259 $b ABA008
- 999 __
- $a ok $b bmc $g 1451816 $s 1073706
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 72 $c 1 $d 96-118 $e 20180703 $i 1558-3597 $m Journal of the American College of Cardiology $n J. Am. Coll. Cardiol. $x MED00002964
- LZP __
- $a Pubmed-20191007
